For many mental health conditions, effective programs to restore health and social functioning require collaborative efforts that go far beyond the healthcare sector. Individuals who are newly diagnosed with psychosis often require a carefully coordinated mix of specialty services including pharmacotherapy, behavioral counselling, educational services, vocational supports, and supportive housing options.
Populations with diabetes can successfully manage their condition if they have regular access to primary care along with access to quality food, physical, and social environments that support healthy lifestyles. Lack of safe, convenient, and affordable transportation options can make it difficult for low-income populations to access these resources.
American cities face stubbornly large racial disparities in infant mortality, preterm and low birthweight births along with unacceptable rates of maternal mortality. The Los Angeles Maternity Assessment Management Access and Service (MAMA) program is an innovative, multi-sector initiative that seeks to address the constellation of social factors that contribute to adverse maternal and infant outcomes, including housing instability, food insecurity, untreated mental health conditions, domestic violence, and substance abuse.
A vast majority of older Americans who are eligible for federal nutrition assistance programming remained unenrolled, placing them at increased risk of food insecurity and its associated adverse health conditions and healthcare costs. A research team led by Benefits Data Trust and the UPMC Center for High-Value Healthcare will study the health and economic effects of a novel health plan strategy to increase benefit program enrollment.
Children affected by the opioid epidemic need a complex array of services and supports to safeguard their health and wellbeing, including child protective services, legal representation, educational services, comprehensive physical and mental health care, and often foster care placement coupled with family reunification strategies. Timely access to these services is especially difficult in rural areas.
Traditional value assessment frameworks that focus solely on a narrowly defined cost effectiveness perspective do not adequately reflect the broader value of innovation. The potential introduction of new medicines to treat Alzheimer’s Disease challenges existing frameworks. Increasingly, discussion is focusing on extending the paradigm to capture broader elements of value (e.g.
One Health recognizes the existential interconnectedness of humans, animals and their shared environment. It is key to ensuring the healthy and sustainable future of the planet and the people, flora and fauna that live on it. One Health encompasses topics such as inter-species transmission of infectious agents (zoonoses), antimicrobial resistance, economics of One Health programs, and One Health in sustainable food systems.
Determining reliable estimates of the survival gain offered by new therapies compared to standard of care is a critical component in establishing their incremental cost-effectiveness. Inaccurate results will lead to inappropriate estimates of lifetime health benefit and ultimately sub-optimal healthcare decision-making. New technologies with different mechanisms of action can have distinct and complex patterns of survival bringing new challenges for the assessment of their long-term benefit.In this webinar, we will be discussing this issue in relation to cancer immunotherapy.
The webinar will present an overview of societal benefits of biosimilars, how these are measured, how the United States (US) and select markets are tracking in attaining these benefits, and potential solutions for advancing the evidence of potential benefits into action. By way of societal benefits, biosimilars have been widely expected to improve patient access to life-saving biologics while reflecting in substantial cost savings. A RAND report estimates US cost savings of over $50 billion in 10 years. However, there is wide variability in the estimates as to how biosimilars may benefit
COVID-19 has put unprecedented strain on the healthcare workforce, as it has demanded significant clinical resources and challenged staff wellbeing. This webinar will explore how health systems can efficiently manage staffing during the pandemic with a human-first approach, putting people at the forefront of decisions. This session will focus on recruitment and retention, managing employee burnout and the importance of workplace culture. Join this webinar to learn: